• pagcor slot
  • pagcor slot online
  • tol777
  • slot tol777
  • tol777
  • slot tol777
  • tol777
  • slot tol777
  • rom88
  • slot rom88
  • Drug Pricing

    Commentary

    Read the latest on drug price controls

    Dems’ Drug Price Controls Would Mean Fewer Drugs And Fewer Jobs

    Hundreds of lifesaving therapies will never be invented, and as many as 1.1 million jobs will be lost if Senate Democrats successfully expand their prescription drug price-fixing program, according to a major new study. The study, conducted by the research group Vital Transformation, modeled the effects of the SMART Prices Act. Sponsored ...
    Drug Innovation

    NEW BRIEF: Cash-Based Support Would Empower Vulnerable to Buy Private Health Insurance, Create More Effective Safety Net

    Click to download the brief “Tens of millions are stuck in a flawed government-run healthcare system that provides sub-par care to patients, imposes huge taxpayer costs, and harms the broader healthcare system,” said Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and the series author. “By providing cash-based ...
    Commentary

    Read the latest on the Inflation Reduction Act's drug pricing reforms

    Merck Fighting for Rights, Market-based Health Care

    Pharmaceutical giant Merck announced last week that it is taking the federal government to court over the Inflation Reduction Act’s drug pricing reforms. The lawsuit alleges that the law’s Medicare price negotiation program violates some of the most fundamental rights guaranteed by the U.S. Constitution. “This is not ‘negotiation,'” the company says ...
    Commentary

    Read how shoplifting effects pharmacy shortages

    Pharmacies Keep Closing: Blame Shoplifting and Intentional Pharmacist Shortages

    While local and national media outlets frequently report on food deserts, particularly in cities that lack sufficient grocery stores, there is one major shortage that goes largely unnoticed by the press: pharmacies. “Pharmacy deserts” pose a real threat, particularly for vulnerable populations. This is something I’ve seen firsthand. Last year, ...
    Drug Pricing

    Bill Smith – Rationing Medicine

    Bill Smith of the Pioneer Institute in Massachusetts joins Wayne and Tim to discuss his important new book “Rationing Medicine”, which focuses on an obscure economic concept called QALYs – or quality adjusted life years. 
    Commentary

    New COVID-19 research is troubling

    Gov’t Undermines Search for Heart Disease Treatments

    New research into COVID-19 has revealed some troubling findings. Even mild cases can lead to lasting heart complications. Comparing test data collected before and after a group of patients in their mid-30s contracted mild cases of COVID, researchers noticed an increase in arterial stiffness and cardiovascular inflammation. That means they may face “a widespread ...
    Commentary

    Read latest on drug pricing

    The Continuing Danger From Progressive’s Faulty Excess Profit Allegations

    Sen. Bernie Sanders (D-Vermont) and Rep. Alexandria Ocasio-Cortez (D-New York) continuously confirm Alexander Pope’s famous maxim about a little bit of knowledge. It truly is a dangerous thing, especially in the hands of politicians. During a May 11th meeting of the Senate Health, Education, Labor and Pensions (HELP) committee, Sen. ...
    Commentary

    Today's commentary on pharmaceutical benefit managers

    Will Senate Hearing Expose PBMs’ Unscrupulous Drug Pricing Tactics?

    Today , Sen. Bernie Sanders, I-Vt., will haul executives from three insulin manufacturers and three pharmacy benefit managers before the Senate Health, Education, Labor and Pensions Committee for a hearing on “the need to make insulin affordable for all Americans.” Sen. Sanders is sure to call the pharmaceutical executives — ...
    Commentary

    Thank the IRA for Cuts to Critical Drug Research

    President Biden’s Inflation Reduction Act is just eight months old. It hasn’t yet slayed inflation. But it’s already gutting drug research and development. The law gives Medicare the power to impose price controls on certain prescription drugs for the first time. By September, federal officials will select the first 10 ...
    Commentary

    Small-Molecule Price Controls Are A Big Mistake

    The Biden administration is in the midst of setting the terms for its program of price controls on prescription drugs dispensed through Medicare. The first 10 medicines subject to the price caps will be selected by the end of this year. That prospect is already chilling investment in drug research, particularly ...
    Commentary

    Read the latest on drug price controls

    Dems’ Drug Price Controls Would Mean Fewer Drugs And Fewer Jobs

    Hundreds of lifesaving therapies will never be invented, and as many as 1.1 million jobs will be lost if Senate Democrats successfully expand their prescription drug price-fixing program, according to a major new study. The study, conducted by the research group Vital Transformation, modeled the effects of the SMART Prices Act. Sponsored ...
    Drug Innovation

    NEW BRIEF: Cash-Based Support Would Empower Vulnerable to Buy Private Health Insurance, Create More Effective Safety Net

    Click to download the brief “Tens of millions are stuck in a flawed government-run healthcare system that provides sub-par care to patients, imposes huge taxpayer costs, and harms the broader healthcare system,” said Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and the series author. “By providing cash-based ...
    Commentary

    Read the latest on the Inflation Reduction Act's drug pricing reforms

    Merck Fighting for Rights, Market-based Health Care

    Pharmaceutical giant Merck announced last week that it is taking the federal government to court over the Inflation Reduction Act’s drug pricing reforms. The lawsuit alleges that the law’s Medicare price negotiation program violates some of the most fundamental rights guaranteed by the U.S. Constitution. “This is not ‘negotiation,'” the company says ...
    Commentary

    Read how shoplifting effects pharmacy shortages

    Pharmacies Keep Closing: Blame Shoplifting and Intentional Pharmacist Shortages

    While local and national media outlets frequently report on food deserts, particularly in cities that lack sufficient grocery stores, there is one major shortage that goes largely unnoticed by the press: pharmacies. “Pharmacy deserts” pose a real threat, particularly for vulnerable populations. This is something I’ve seen firsthand. Last year, ...
    Drug Pricing

    Bill Smith – Rationing Medicine

    Bill Smith of the Pioneer Institute in Massachusetts joins Wayne and Tim to discuss his important new book “Rationing Medicine”, which focuses on an obscure economic concept called QALYs – or quality adjusted life years. 
    Commentary

    New COVID-19 research is troubling

    Gov’t Undermines Search for Heart Disease Treatments

    New research into COVID-19 has revealed some troubling findings. Even mild cases can lead to lasting heart complications. Comparing test data collected before and after a group of patients in their mid-30s contracted mild cases of COVID, researchers noticed an increase in arterial stiffness and cardiovascular inflammation. That means they may face “a widespread ...
    Commentary

    Read latest on drug pricing

    The Continuing Danger From Progressive’s Faulty Excess Profit Allegations

    Sen. Bernie Sanders (D-Vermont) and Rep. Alexandria Ocasio-Cortez (D-New York) continuously confirm Alexander Pope’s famous maxim about a little bit of knowledge. It truly is a dangerous thing, especially in the hands of politicians. During a May 11th meeting of the Senate Health, Education, Labor and Pensions (HELP) committee, Sen. ...
    Commentary

    Today's commentary on pharmaceutical benefit managers

    Will Senate Hearing Expose PBMs’ Unscrupulous Drug Pricing Tactics?

    Today , Sen. Bernie Sanders, I-Vt., will haul executives from three insulin manufacturers and three pharmacy benefit managers before the Senate Health, Education, Labor and Pensions Committee for a hearing on “the need to make insulin affordable for all Americans.” Sen. Sanders is sure to call the pharmaceutical executives — ...
    Commentary

    Thank the IRA for Cuts to Critical Drug Research

    President Biden’s Inflation Reduction Act is just eight months old. It hasn’t yet slayed inflation. But it’s already gutting drug research and development. The law gives Medicare the power to impose price controls on certain prescription drugs for the first time. By September, federal officials will select the first 10 ...
    Commentary

    Small-Molecule Price Controls Are A Big Mistake

    The Biden administration is in the midst of setting the terms for its program of price controls on prescription drugs dispensed through Medicare. The first 10 medicines subject to the price caps will be selected by the end of this year. That prospect is already chilling investment in drug research, particularly ...